Sedation with orally administered midazolam in elderly dental patients with major neurocognitive disorder
Authors:
- 17 February 2017
- journal article
- Published by Wiley in Gerodontology
- Vol. 34 (3) , 299-305
Abstract
Objective: The aim of this study was to evaluate acceptance of treatment after oral sedation with midazolam in dental patients with major neurocognitive disorder.Background: Midazolam is commonly used as premedication in paediatric dentistry, oral surgery and people suffering from dental fear. Little is known about its use in other patient groups.Methods: Dental and sedation records of 61 patients (64% women) sedated with midazolam were examined retrospectively. All records came from patients with major neurocognitive disorder who had been referred to a special dental care unit in Sweden due to uncooperative behaviour and sedated with orally administered midazolam between 2006 and 2011. Data concerning dose, degree of acceptance of dental treatment (four‐point scale) and number of possible interacting drugs were collected from dental records.Results: On average, the participants were 80 years old (range: 62‐93) and used 3.4 possible interacting drugs. The average midazolam dose was 0.11 mg/kg body weight, which is in line with the regional medical guidelines for sedation. Twenty‐seven participants (44%) had no cooperation problems when sedated, twenty‐six (43%) were treated with minor adaptations, five had poor cooperation, and three were not possible to treat. No statistically significant differences were found for degree of acceptance of treatment and dose or number of possible interacting drugs. Antiepileptics were used by 13% (n=7) with good or quite good acceptance compared to 37% (n=3) among those with poor or no acceptance. Unfavourable side effects were rare; one participant became hyperactive and one drowsier than expected.Conclusion: Sedation with orally administered midazolam seems to be effective and safe in dental treatment of uncooperative persons with major neurocognitive disorder.Keywords
Funding Information
- Local Research and Development Board for Gothenburg and Södra Bohuslän.
This publication has 19 references indexed in Scilit:
- Trends in tooth loss in relation to socio-economic status among Swedish women, aged 38 and 50 years: repeated cross-sectional surveys 1968-2004BMC Oral Health, 2013
- Conscious Sedation Procedures Using Intravenous Midazolam for Dental Care in Patients with Different Cognitive Profiles: A Prospective Study of Effectiveness and SafetyPLOS ONE, 2013
- Oral status in home‐dwelling elderly dependent on moderate or substantial supportive care for daily living: prevalence of edentulous subjects, caries and periodontal diseaseGerodontology, 2011
- Increasing polypharmacy - an individual-based study of the Swedish population 2005-2008BMC Clinical Pharmacology, 2010
- Intranasal/intravenous sedation for the dental care of adults with severe disabilities: a multicentre prospective auditBritish Dental Journal, 2010
- Dementia and DysphagiaGeriatric Nursing, 2008
- Retrospective audit of the efficacy and safety of the combined intranasal/intravenous midazolam sedation technique for the dental treatment of adults with learning disabilityBritish Dental Journal, 2008
- Effectiveness of Oral Midazolam for Paediatric Dental Care: A retrospective study in two Specialist CentresEuropean Archives of Paediatric Dentistry, 2006
- Oral midazolam sedation in third molar surgeryInternational Journal of Oral and Maxillofacial Surgery, 1987
- MidazolamAnesthesiology, 1985